Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Heusden-Zolder, Belgium Clinical Trials

A listing of Heusden-Zolder, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (9) clinical trials

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

In the majority of European countries, the primary management of chronic heart failure patients is performed by General Practitioners in collaboration with cardiologists (specialists). Previous studies have shown that many patients suffering from CHF do not receive optimal pharmacological and/or device treatment for their disease. An increase in natriuretic peptides ...

Phase

6.57 miles

Learn More »

European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)

The EuroEco is a prospective, international, randomized study aimed at assessing the economic effects of BIOTRONIK Home Monitoring (HM) technology as compared with traditional follow up (FU) of ICD and CRT-D patients from two perspectives: 1) the cost-effectiveness for the payer of health care, and 2) the economic impact on ...

Phase

7.67 miles

Learn More »

Evaluation of Ablation Index and VISITAG (ABI-173)

The purpose of this study is to assess the safety, acute and long term effectiveness, during standard RF ablation procedures while using Ablation Index and VISITAG software in combination with a Thermocool SmartTouch (ST) or SmartTouch Surroundflow (STSF) catheter. Furthermore, the role of Ablation Index and VISITAG workflow in creating ...

Phase

7.67 miles

Learn More »

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

Estrogens are responsible for the disappearance of growth cartilage in the long bones at the end of the pubertal growth spurt both in boys and in girls. It is therefore hypothesized that stopping pubertal development and hence estrogen production, will prolong and increase the pubertal growth spurt, especially when growth ...

Phase

8.25 miles

Learn More »

Long-term Open-label Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod

This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events

Phase

8.42 miles

Learn More »

Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study

Eligibility criteria: - 18 to 85 years. - Evidence of myocardial ischemia without raised troponin (e.g. stable or unstable angina, silent ischemia demonstrated by positive territorial functional study). - The patient has a planned intervention of up to two de novo lesions in different epicardial vessels - Lesion(s) must have ...

Phase

8.42 miles

Learn More »

Absorbable Versus Permanent Mesh Fixation Trial in Laparoscopic Midline Ventral Hernia Repair

To compare the use of absorbable tackers versus permanent tack fixation using a polyester large pore mesh in laparoscopic midline ventral hernia repair in a multicenter (Belgian) prospective randomized single-blinded trial. All patients referred for elective midline ventral hernia repair should be assessed for eligibility and entered in a study ...

Phase

8.42 miles

Learn More »

Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy

To assess impact on left ventricular reverse remodeling defined as a change in left ventricular ejection fraction in heart failure patients with reduced ejection fraction (and previous implantation of cardiac resynchronization therapy) undergoing treatment with ferric carboxymaltose vs. placebo

Phase

8.42 miles

Learn More »

COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

In the Care in Rheumatoid Arthritis (CareRA) trial (NCT01172639) about 70% of early RA patients are in remission at the 2 year evaluation point independent of the combination scheme used. Interesting to see is that the 30% of insufficient responders can be identified in an early stage of the treatment ...

Phase

8.42 miles

Learn More »